These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28159712)

  • 1. Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.
    Clinkenbeard EL; White KE
    Bone; 2017 Sep; 102():31-39. PubMed ID: 28159712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
    Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B
    PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23.
    Fukumoto S; Yamashita T
    Bone; 2007 May; 40(5):1190-5. PubMed ID: 17276744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).
    Farrow EG; Imel EA; White KE
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):735-47. PubMed ID: 22142751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control].
    Prié D; Ureña Torres P; Friedlander G
    Med Sci (Paris); 2009 May; 25(5):489-95. PubMed ID: 19480830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate homeostasis disorders.
    Christov M; Jüppner H
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):685-706. PubMed ID: 30449549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibroblast growth factor-23 (FGF-23). Part I. Significance in phosphate homeostasis and bone metabolism].
    Fedak D; Bigaj K; Sułowicz W
    Przegl Lek; 2011; 68(4):231-8. PubMed ID: 21853680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrine control of serum phosphate: from the discoveries of phosphatonins to novel therapies].
    Linglart A; Chaussain C
    Ann Endocrinol (Paris); 2016 Oct; 77 Suppl 1():S36-S42. PubMed ID: 28645356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis.
    White KE; Hum JM; Econs MJ
    Curr Osteoporos Rep; 2014 Sep; 12(3):252-62. PubMed ID: 24980542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
    Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
    Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.
    Hori M; Shimizu Y; Fukumoto S
    Endocrinology; 2011 Jan; 152(1):4-10. PubMed ID: 21084445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity.
    Clinkenbeard E
    Calcif Tissue Int; 2023 Jul; 113(1):4-20. PubMed ID: 37306735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor as a potential candidate for phosphate sensing.
    Takashi Y; Fukumoto S
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):446-452. PubMed ID: 32427693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in renal phosphate handling.
    Farrow EG; White KE
    Nat Rev Nephrol; 2010 Apr; 6(4):207-17. PubMed ID: 20177401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.